Abacavir Sulfate CAS Number 188062-50-2

Abacavir sulfate, chemically defined as chemical identifier 188062-50-2, acts as a highly effective HIV medication. It suppresses the proliferation of the human immunodeficiency virus (HIV) by preventing the viral enzyme reverse transcriptase. This enzyme is essential in the HIV life cycle, enabling the virus to integrate its genetic material into

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate serves as a nucleoside reverse transcriptase inhibitor employed in the management of human immunodeficiency virus infection. Its therapeutic properties stem from the selective inhibition of reverse transcriptase, an enzyme vital for HIV replication. Abacavir sulfate is a derivative that undergoes conversion to its active form, car

read more

Leading API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for businesses of all sizes. A leading global API manufacturer and supplier provides a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a proven commitment to quality, innovation, and cust

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside analog reverse transcriptase inhibitor. Its mechanism of action involves the competitive suppression of HIV-1 reverse transcriptase, an enzyme crucial for viral replication. Abacavir sulfate exerts its influence by being incorporated into the growing DNA chain during reverse transcription, leading to premature halt.

read more

India's Leading Nutraceutical API Manufacturer

India has firmly established itself as a global hub for nutraceutical ingredient production, particularly in the realm of Active Pharmaceutical Ingredients (compounds). Numerous Indian firms specialize in the specialized production of wellness APIs, serving both the national market and exporting globally. These companies boast advanced facilities,

read more